Working in silos, change will not occur. WBC convenes with our Partners, Champions, and Sponsors to move faster together toward our action initiative goals.
Join us for Our Annual Action for Impact Summit!
WBC’s Annual Action for Impact Summit unites thousands of attendees on a fully interactive platform, enabling participants to network, connect, and exchange ideas, innovations, and impact in real time.
WOMEN CEO REPORT
Dr. Martine A. Rothblatt is Chair, CEO & Founder of United Therapeutics Corp., a Chief Executive Officer at Revivicor, Inc. and a President & CEOat Lung Biotechnology PBC. Martine was previously chairman & CEO of SIRIUS Satellite Radio, Inc. She also served on the board at Synthetic Genomics, Inc. She is currently on the Board of Directors at United Therapeutics Europe Ltd., Beta Technologies, Inc. and The Kennedy Center Corporate Fund. In 2021, the National Business Aviation Association (NBAA) selected her for its highest honor, the Meritorious Service to Aviation Award, for her fostering of aviation weather information on the flight deck and of advanced air mobility such as electric helicopters. She received her graduate degree from the University of California, Los Angeles, an MBA from the University of California, Los Angeles and a PhD from the University of London.
